WST — WEST PHARMACEUTICAL SERVICES INC
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 105770 ·
Last close
$340.96
Market Cap
$24.00B
52W High
$385.75
52W Low
$294.08
ADV30
898,177
Next earnings
2026-10-22
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 872,300,000 | 329,200,000 | 191,900,000 | 154,000,000 | 4,076,400,000 | 435,800,000 | 1,086,200,000 |
| Mar 2026 | 844,900,000 | 296,400,000 | 181,100,000 | 138,800,000 | 4,109,800,000 | 521,400,000 | 1,119,400,000 |
| Dec 2025 | 805,000,000 | 303,900,000 | 175,100,000 | 132,100,000 | 4,270,000,000 | 791,300,000 | 1,094,000,000 |
| Sep 2025 | 804,600,000 | 294,300,000 | 174,500,000 | 140,000,000 | 4,105,800,000 | 628,500,000 | 1,054,300,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$662,200,000
Investing CF
$-225,300,000
Financing CF
$-496,700,000
CapEx
$-225,300,000
Dividends Paid
$-62,400,000
Buybacks
$-457,100,000
EPS Diluted TTM
$7.81
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$4,624,100,000
Inventory
$447,400,000
Receivables
$712,000,000
ST Investments
—
EBIT TTM
$698,100,000
Pretax Income TTM
$693,600,000
Interest Exp TTM
$4,500,000
Analysts
15
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,326,799,872
EBITDA
$912,200,000
Free Cash Flow
$277,937,504
Enterprise Value
$23,876,020,224
Total Cash
$435,800,000
Total Debt
$316,500,000
Shares Out
70,375,762
Trailing EPS
$7.81
Book Value
$42.18
ROE
19.1%
ROA
11.4%
Div Yield
0.26%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,074,100,000 | 636,100,000 | 493,700,000 | 4,270,000,000 | 1,094,000,000 | — | 754,800,000 |
| Dec 2024 | 2,893,200,000 | 590,900,000 | 492,700,000 | 3,643,400,000 | 961,100,000 | — | 653,400,000 |
| Dec 2023 | 2,949,800,000 | 707,400,000 | 593,400,000 | 3,829,500,000 | 948,500,000 | — | 776,500,000 |
| Dec 2022 | 2,886,900,000 | 760,800,000 | 585,900,000 | 3,616,800,000 | 931,900,000 | — | 724,000,000 |
TTM Snapshot
Revenues TTM
$2,887,700,000
NetIncome TTM
$593,500,000
OpCashFlow TTM
$0
Assets (Latest)
$3,643,400,000
Forward EPS
$9.96
Max Pain — expiry 2026-12-18
max pain strike: $280.00 · spot: $340.96 · call oi: 780 · put oi: 686Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RSMDF | RESMED INC | $24.25B | $16.72 | — |
| RYLPF | KONINKLIJKE PHILIPS NV | $24.50B | $25.07 | — |
| PHG | KONINKLIJKE PHILIPS NV | $25.71B | $26.30 | — |
| STE | STERIS plc | $22.26B | $228.40 | — |
| FSNUY | Fresenius SE & Co. KGaA | $29.02B | $12.88 | — |
News headlines (Yahoo Finance, 1h cache)
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call
2026-08-01 14:59 · Yahoo
3 Reasons to Avoid WST and 1 Stock to Buy Instead
2026-08-01 09:15 · Yahoo
3 Cash-Heavy Stocks We Approach with Caution
2026-07-31 16:51 · Yahoo
MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised
2026-07-31 15:08 · Yahoo
Resmed's Q4 Earnings on Deck: What's in Store for the Stock?
2026-07-31 13:32 · Yahoo
SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery
2026-07-31 13:31 · Yahoo
BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract
2026-07-30 16:02 · Yahoo
Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up
2026-07-30 15:55 · Yahoo
GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
2026-07-29 15:42 · Yahoo
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
2026-07-29 15:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.